Bill Text: TX SB309 | 2023-2024 | 88th Legislature | Introduced
Bill Title: Relating to COVID-19 prevention and treatment information provided to individuals receiving a COVID-19 viral test.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2023-02-15 - Referred to Health & Human Services [SB309 Detail]
Download: Texas-2023-SB309-Introduced.html
| 88R986 EAS-F | ||
| By: Hall | S.B. No. 309 | |
|
|
||
|
|
||
| relating to COVID-19 prevention and treatment information provided | ||
| to individuals receiving a COVID-19 viral test. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Chapter 81, Health and Safety Code, is amended by | ||
| adding Subchapter K to read as follows: | ||
| SUBCHAPTER K. COVID-19 TESTING, PREVENTION, AND TREATMENT | ||
| Sec. 81.451. DEFINITIONS. In this subchapter: | ||
| (1) "COVID-19" means the 2019 novel coronavirus | ||
| disease. | ||
| (2) "Health care provider" means a person who is | ||
| licensed, certified, or otherwise authorized to provide COVID-19 | ||
| viral testing. | ||
| Sec. 81.452. COVID-19 PREVENTION AND TREATMENT | ||
| INFORMATION. The department shall post on the department's | ||
| Internet website a printable brochure containing information on | ||
| preventative measures and treatments for COVID-19. The brochure | ||
| must include the following information: | ||
| (1) methods to improve the functioning of an | ||
| individual's immune system; | ||
| (2) the importance of therapeutic prevention of | ||
| COVID-19, including: | ||
| (A) the use of nutraceuticals; | ||
| (B) the use of prescription medications; and | ||
| (C) the benefits and risks associated with | ||
| vaccination; | ||
| (3) the importance of seeking treatment for COVID-19 | ||
| as soon as symptoms appear and a list of COVID-19 treatments that | ||
| may be effective, including available medications; and | ||
| (4) advanced home treatments for reducing COVID-19 | ||
| symptoms and preventing hospitalization after an individual | ||
| contracts COVID-19, including monoclonal antibody therapy. | ||
| Sec. 81.453. REQUIREMENTS FOR HEALTH CARE PROVIDERS. A | ||
| health care provider who performs a COVID-19 viral test on an | ||
| individual shall, at the time the provider performs the test, | ||
| provide a printed or electronic copy of the brochure described by | ||
| Section 81.452 to the individual. | ||
| SECTION 2. As soon as practicable after the effective date | ||
| of this Act, the Department of State Health Services shall develop | ||
| and post on the department's Internet website the brochure required | ||
| by Section 81.452, Health and Safety Code, as added by this Act. | ||
| SECTION 3. This Act takes effect immediately if it receives | ||
| a vote of two-thirds of all the members elected to each house, as | ||
| provided by Section 39, Article III, Texas Constitution. If this | ||
| Act does not receive the vote necessary for immediate effect, this | ||
| Act takes effect September 1, 2023. | ||
